These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Exempt, with results||2008-003967-37||Safety and efficacy trial of a RNActive®-derived prostate cancer vaccine in hormone refractory disease||2012-12-10||not-yet-due|
|Exempt, with results||2008-007785-39||Safety and efficacy phase I/IIa trial of an RNActive®-derived cancer vaccine in stage IIIB/IV non small cell lung cancer (NSCLC)||2014-02-25||not-yet-due|
|Exempt, with results Terminated||2011-006314-14||A Randomised, Double-blind, Placebo-controlled, Phase I/II Trial of RNActive®-derived Cancer Vaccine (CV9104) in Asymptomatic or Minimally Symptomatic Patients with Metastatic Castrate-refractory Pros...||2017-01-19||not-yet-due|
|Completed, but no date, and reported results Terminated||2013-004489-32||An open label Randomised Phase II Trial of RNActive® Cancer Vaccine (CV9104) in high risk and intermediate risk patients with prostate cancer||bad-data|